About this product

PAX's fresh-pressed live rosin with natural THC, terpenes & flavonoids for high potency, perfectly balanced 'full flower' experience. PAX's mission is to premiumize the vape consumer matching the high device quality our consumers are accustomed to. PAX aims to improve the vape consumers' experience by converting 510 users to PAX Era's superior technology with only a 0.05% fail rate. PAX entering the vape market will increase the current Era install base of over 175,000 users in Canada to help elevate the vape consumer experience. Pax is looking to mimic 0.5g vape success; in 2022, Pax accounts for a 9.6% share of 0.5g vape at OCS. Pax will build off of PAX USA vape success and launch innovative strains that have been validated in the California market throughout 2023.